GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | TNFRSF10B | affects response to substance | EXP | | 6480464 | CTD | TNFRSF10B affects the susceptibility to Arsenic Trioxide | PMID:18172319 | TNFRSF10B | increases expression | EXP | | 6480464 | CTD | Arsenic Trioxide results in increased expression of TNFRSF10B; Arsenic Trioxide results in increased expression of TNFRSF10B mRNA; Arsenic Trioxide results in increased expression of TNFRSF10B protein | PMID:12851490 PMID:16434995 PMID:18172319 PMID:19939880 PMID:24345465 PMID:24377552 PMID:26705709 PMID:27430728 | TNFRSF10B | multiple interactions | EXP | | 6480464 | CTD | [Arsenic Trioxide co-treated with Buthionine Sulfoximine] results in increased expression of TNFRSF10B protein; [Arsenic Trioxide co-treated with Curcumin] results in increased expression of TNFRSF10B protein; [Bortezomib co-treated with Arsenic Trioxide] results in increased expression of TNFRSF10B protein; [sanguinarine co-treated with Arsenic Trioxide] results in increased expression of TNFRSF10B mRNA; [sanguinarine co-treated with Arsenic Trioxide] results in increased expression of TNFRSF10B protein; Bortezomib promotes the reaction [Arsenic Trioxide results in increased activity of TNFRSF10B]; DDIT3 affects the reaction [Arsenic Trioxide results in increased expression of TNFRSF10B]; DDIT3 mutant form inhibits the reaction [Arsenic Trioxide results in increased expression of TNFRSF10B protein]; pyrazolanthrone inhibits the reaction [[Arsenic Trioxide co-treated with Buthionine Sulfoximine] results in increased expression of TNFRSF10B protein]; TP53 protein affects the reaction [Arsenic Trioxide results in increased expression of TNFRSF10B protein] | PMID:12851490 PMID:17145888 PMID:18172319 PMID:19939880 PMID:20471514 PMID:24345465 PMID:24377552 PMID:27430728 | |
Go Back to source page | Continue to Ontology report |